Onesource Specialty Pharma Limited CC-Jun25.pdf
4 Aug 2025
-
Yes, hi. Thank you for taking my question. My question was beyond GLP-1, are there any other therapeutic areas or delivery platforms where you see potential for platform expansion?
Read in transcript